Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Looks To Make Its Big Pharma Engine More Agile By Cutting 10,000

This article was originally published in The Pink Sheet Daily

Executive Summary

Company's reorganization will include R&D rationalization, manufacturing consolidation and European field force cuts.

You may also be interested in...



Pfizer Avoids Japan R&D Layoffs With Creation Of New Business

Company spins off part of Nagoya research site into venture-backed RaQualia Pharma.

Pfizer Avoids Japan R&D Layoffs With Creation Of New Business

Company spins off part of Nagoya research site into venture-backed RaQualia Pharma.

Pfizer Spins Off Esperion While Retaining Former Subsidiary’s Top Compounds

Pfizer retains undisclosed stake in Esperion, which will focus on small-molecule dyslipidemia candidate.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS065056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel